Biopôle Lausanne

🤝 We're delighted to announce that the Swiss Data Science Center will be establishing its national headquarters at the Biopôle campus. The arrival of this joint initiative between EPFL and ETH Zürich – supported by the Canton of Vaud (Etat de Vaud) – will bring cutting-edge expertise in data science and AI to the Biopôle community and represents a significant step forward for our region’s innovation ecosystem.   We look forward to the new opportunities for growth, collaboration and impact this new initiative will bring.   👇 For more info, check out the SDSC post and press release below.

👀 Have you seen the exciting life sciences events coming up in western Switzerland? BioAlps - Life Sciences Cluster 🇨🇭Networking Day (Today!) With a focus on sustainability in nutrition and health, this event brings together 300 key players from the Swiss Health Valley, including representatives from academia, start-ups, government and media. EPFL Investor Day This event offers an opportunity for the wider investment community to engage with the most innovative tech start-ups from western Switzerland. Faces of Industrial Research 2025 At this event, scientists from various sectors showcase their scientific projects, reveal inspiring career journeys and provide invaluable insights into the transition from academia to industry. 👉 Find more information and register here: https://lnkd.in/dXRPt5d4

📈 When Olivier Philippe joined Biopôle in 2016, there were only around 20 life sciences companies on site. Now, 8 years later, there are more than 150!   As Biopôle SA's Corporate Relations and Business Development Director, Olivier had a big part to play in that transformation.   But what does he actually do from day to day? 👉 Promote Biopôle by demonstrating to interested parties why it's the right place for them and the right ecosystem to be part of  👉 Support companies and organisations to set up and grow their operations on campus 👉 Help them to foster new collaborations and business opportunities by connecting them with potential partners (e.g. industry partners, investors and research organisations)   ✨ Olivier's enthusiasm for his work is obvious: 'The Biopôle campus is just awesome. We have modern infrastructure, state-of-the-art technology platforms and R&D facilities, easy access to public transport, lots of amenities and services – and a beautiful view over Lake Geneva. But what impresses me most is the level of science and innovation we have on site. When I do a site visit with prospects or delegations, I am really amazed by the outstanding technologies that are under development here. It's a joy to work in such a vibrant and dynamic innovation hub!'    🙏 And we're delighted you're a part of it too, Olivier. Thank you for your dedication to the Biopôle community.

💰 As much as 20% of Swiss healthcare expenditure today is spent on unnecessary or inadequate care. Could value-based healthcare (VBHC) stop this wastage and be the solution to rising healthcare costs? If so, how might it work practically? We asked Noémie Voeffray Remacle, Head of Transformation at Groupe Mutuel, these questions for our November newsletter. She explains how VBHC might switch the focus from quantity of treatments to quality of care, while also saving money. 👉 Discover her insights in the full article here: https://lnkd.in/efRCU5Fd

🍁 As the seasons continue to change, we take a moment to celebrate some of the latest #BiopôleNews: 🤝 Atinary Technologies has shared news of the launch of the Atinary Lab, a Self-driving Laboratory™. It will contribute to setting new standards for tackling complex challenges in the life sciences, bringing to life the potential of SDLabs™, Atinary’s no-code AI platform, alongside cutting-edge autonomous technology. 📜 cAH - centre André Henzelin has warned workers in the alternative and complementary medicine sector of the urgent need to professionalise to comply with federal regulations. 🏅 Aspivix, a leading innovator in gynecological solutions, has announced that its device, Carevix™, has been selected as one of TIME’s Best Inventions of 2024. 👁️ PeriVision has announced that it has obtained CE-marking to commercialise its first medical software product, VR- and AI-based eye testing platform VisionOne, across the EU. 🎉 Distalmotion has been granted De Novo approval by the US Food and Drug Administration (FDA) to market its flagship surgical robot Dexter for adult inguinal hernia repair. 👏 Bravo to all our members on these recent successes. Check out the full stories here: https://lnkd.in/eC6stPac

💰 Are you fundraising for your life sciences innovation? Would you like some help to navigate the challenges of the ever-evolving financing landscape? Join us for a Deep Dive into raising funds in tough times, in partnership with BioAlps - Life Sciences Cluster 🇨🇭 . The event will include presentations from our panel of experienced investors and successful entrepreneurs, followed by a Q&A session and networking apéro. Key details: 📆 Monday 9 December 2024 🕔 5 p.m. to 8 p.m. 📍 Biopôle Lausanne 👉 Learn more and REGISTER here: https://lnkd.in/dC7DqVYP

Rejoignez-nous à la conférence du projet PULSE - Modular Life Science Center, organisée par notre partenaire EPIC Suisse AG et la Chambre vaudoise du commerce et de l'industrie (CVCI) ! 📍 Rendez-vous le 19 novembre prochain, à Cheseaux-sur-Lausanne.

🏥 In 2020 Switzerland spent almost 12% of its GDP on healthcare – but how to ensure that this spending offers value for money? How do you measure a hospital's success? Value-based healthcare (VBHC) is an approach that focuses on patient outcomes and sustainable healthcare costs, but few hospitals are embedding it within their systems. For our November newsletter, we asked Rodolphe Eurin, CEO of Hôpital de La Tour, why VBHC should be part of hospital processes, why it isn't currently and how to make it successful. 👉 Learn more in the full article here: https://lnkd.in/dbWwqRtn

💸 Did you see our poll about international healthcare costs last week? The majority of you correctly guessed that the World Health Organization (WHO) considers 20–40% of the spending to be wasted. But how can that be? Check out our November newsletter articles to find out. This month's edition will explore the topic of value-based healthcare in detail. We interviewed two experts working in the field right now – Rodolphe Eurin, CEO of Hôpital de La Tour, and Noémie Voeffray Remacle, Head of Transformation at Groupe Mutuel – to share their insights. Look out for the upcoming articles. In the meantime, check out the handy infographic below and please leave us a comment, letting us know what you think!👇

⏰ Time to join us on the Biopôle campus? Find your next job here. Currently open positions include: 👉 Lead Robotics Engineer (80~100%) at Emovo Care 👉 Office Manager 60-80% at Novigenix SA 👉 PhD position in Computational Biology applied to T cell Engineering at the Université de Lausanne 👉 Laboratory Technician at the Vaccine Formulation Institute 👉 Quality Engineer (80-100%) at Limula 👉 Five different roles at HAYA Therapeutics Find details on our dedicated jobs page: https://lnkd.in/gYi7VrN